This location provides a provision-by-provision implementation tracking of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) (Pub. L. 108-173). We also offer a summary of the provisions from the legislation.
CMS-4069-N | 221 | Public Meeting on Medicare Advantage Program (Title II); July 21, 2004 | N/A |
CMS-4068-N | 111 | Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs-August 27, 2004 | N/A |
CMS-4069-N | 211 | Public Meeting on Medicare Advantage Program (Title II); July 21, 2004 | N/A |
CMS-4069-N | 201 | Public Meeting on Medicare Advantage Program (Title II); July 21, 2004 | N/A |
CMS-4068-N | 109 | Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs-August 27, 2004 | N/A |
CMS-4068-N | 110 | Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs-August 27, 2004 | N/A |
CMS-4068-N | 104 | Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs-August 27, 2004 | N/A |
CMS-2200-N4 | 106 | State Pharmaceutical Assistance Transition Commission Members and October 14, 2004 Meeting | N/A |
CMS-4068-N | 107 | Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs-August 27, 2004 | N/A |
CMS-4068-N | 106 | Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs-August 27, 2004 | N/A |